Home > Investor > Benchmark by peers

Benchmark by peers

Sopharma can be compared with other companies in the Europe. Below is a comparison between the different main companies which highlights their operating performance as of q4 2015.

Indicator
(BGN '000)
Sopharma KRKA
(Slovenia)
Alkaloid**
(Macedonia)
Richter Gedeon
(Hungary)
Pharmastandard*
(Russia)
Stada
(Germany)
Sales 874,984 2,277,773 250,347 2,306,706 1,159,618 4,136,833
EBITDA 62,766 599,935  36,852 623,818 447,92 737,543
Operating profit 36,440 390,059 24,883 426,567 309,002 437,603
Net profit 22,600 309,383 21,236 344,422 342,298 229,155
Capex 33,284 187,543   210,252   346,182
Non-current assets 401,484 1,929,618 145,844 2,722,084 639,142 3,974,851
Current assets 434,141 1,608,877 157,214 1,957,579 1,390,938 2,454,774
Equity 457,638 2,749,866 244,308 3,876,362 1,361,924 1,992,072
Non-current liabilities 62,492 217,062 2,383 355,237 9,830 2,508,503
Current liabilities 315,495 571,568 56,367 448,063 658,326 1,929,051

*exchange rate of RUB/BGN as at 31.12.2015 is 40.698693                       
**data from the consolidated statemments for the fourth quarter